Pages that link to "Q30412704"

The following pages link to In vivo assessment of amyloid-β deposition in nondemented very elderly subjects (Q30412704):

Displaying 50 items.

• The relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associations (Q26830467) (← links)
• Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research Results (Q27345258) (← links)
• Amyloid, neurodegeneration, and small vessel disease as predictors of dementia in the oldest-old (Q30303122) (← links)
• Markers of cholesterol transport are associated with amyloid deposition in the brain. (Q30406139) (← links)
• Arterial stiffness and β-amyloid progression in nondemented elderly adults. (Q30409084) (← links)
• Pulse wave velocity is associated with β-amyloid deposition in the brains of very elderly adults. (Q30409644) (← links)
• Classification of amyloid-positivity in controls: comparison of visual read and quantitative approaches. (Q30413572) (← links)
• Cognitive trajectories associated with β-amyloid deposition in the oldest-old without dementia (Q30413904) (← links)
• Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings (Q30666527) (← links)
• The common dementias: a pictorial review. (Q30670885) (← links)
• Neuroimaging and genetic risk for Alzheimer's disease and addiction-related degenerative brain disorders (Q30680866) (← links)
• Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of Dementia (Q31033082) (← links)
• Future Directions in Imaging Neurodegeneration (Q31162702) (← links)
• Diagnostic utility of amyloid PET in cerebral amyloid angiopathy-related symptomatic intracerebral hemorrhage (Q33581237) (← links)
• Amyloid burden and neural function in people at risk for Alzheimer's Disease (Q33599047) (← links)
• The overlap between vascular disease and Alzheimer's disease--lessons from pathology (Q34484708) (← links)
• Hippocampal glutamate NMDA receptor loss tracks progression in Alzheimer's disease: quantitative autoradiography in postmortem human brain (Q35060487) (← links)
• Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan (Q35229601) (← links)
• Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum (Q35529715) (← links)
• Review of 'the potential role of arterial stiffness in the pathogenesis of Alzheimer's disease'. (Q35581060) (← links)
• Subjective Cognitive Complaints, Personality and Brain Amyloid-beta in Cognitively Normal Older Adults (Q35940991) (← links)
• Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease (Q35957099) (← links)
• APOε2 and education in cognitively normal older subjects with high levels of AD pathology at autopsy: findings from the Nun Study (Q35987278) (← links)
• Reduced binding of Pittsburgh Compound-B in areas of white matter hyperintensities (Q36146058) (← links)
• Individual estimates of age at detectable amyloid onset for risk factor assessment (Q36827330) (← links)
• Psychological, behavioral and social effects of disclosing Alzheimer's disease biomarkers to research participants: a systematic review. (Q37406073) (← links)
• Amyloid-beta and depression in healthy older adults: a systematic review. (Q38270148) (← links)
• The pleiotropic vasoprotective functions of high density lipoproteins (HDL). (Q38760636) (← links)
• Molecular and cellular pathophysiology of preclinical Alzheimer's disease (Q38836004) (← links)
• Biomarkers for the Early Detection and Progression of Alzheimer's Disease (Q38979999) (← links)
• Polyphenols Beyond Barriers: A Glimpse into the Brain. (Q38991608) (← links)
• The relationship between amyloid deposition, neurodegeneration, and cognitive decline in dementia. (Q39128635) (← links)
• Association of Brain Amyloid-β With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E ε4 Genotype. (Q39189440) (← links)
• Detectable Neuropsychological Differences in Early Preclinical Alzheimer's Disease: A Meta-Analysis (Q39301541) (← links)
• Vascular Health Indices and Cognitive Domain Function: Singapore Longitudinal Ageing Studies (Q41071514) (← links)
• Amyloid PET imaging: applications beyond Alzheimer's disease (Q43161462) (← links)
• The association of Aβ amyloid and composite cognitive measures in healthy older adults and MCI. (Q45987495) (← links)
• Synergistic effects of ischemia and β-amyloid burden on cognitive decline in patients with subcortical vascular mild cognitive impairment (Q46454611) (← links)
• Small-molecule PET Tracers for Imaging Proteinopathies (Q47926474) (← links)
• Case 1-2017. A 70-Year-Old Woman with Gradually Progressive Loss of Language (Q48362816) (← links)
• Cerebral Amyloid Deposition and Dual-Tasking in Cognitively Normal, Mobility Unimpaired Older Adults (Q48445964) (← links)
• Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE ɛ4 genotype. (Q53397288) (← links)
• Apolipoproteins and Alzheimer's pathophysiology (Q58129974) (← links)
• Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging (Q58560845) (← links)
• Amyloid deposition and brain structure as long-term predictors of MCI, dementia, and mortality (Q88475507) (← links)
• The Relationship of Current Cognitive Activity to Brain Amyloid Burden and Glucose Metabolism (Q89051261) (← links)
• Alcohol Consumption, Brain Amyloid-β Deposition, and Brain Structural Integrity Among Older Adults Free of Dementia (Q89626412) (← links)
• Longitudinal Maintenance of Cognitive Health in Centenarians in the 100-plus Study (Q89891729) (← links)
• The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies (Q92239415) (← links)
• The effect of amyloid deposition on longitudinal resting-state functional connectivity in cognitively normal older adults (Q92451639) (← links)